Home › Major Depressive Disorder › Ohio › Akron
Major Depressive Disorder clinical trials in Akron, OH
4 studies for Major Depressive Disorder are looking for participants at sites in and around Akron (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
RecruitingPhase 2
- Seaport Investigator Site, North Canton · 15 mi away
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
RecruitingPhase 2
- Neuro-Behavioral Clinical Research, North Canton · 15 mi away
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
RecruitingPhase 3
- Neuro-Behavioral Clinical Research, North Canton · 15 mi away
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
RecruitingPhase 2
- Neuro Behavioral Clinical Research, Inc., North Canton · 15 mi away
Major Depressive Disorder trials in other cities
- New York City, NY37 studies
- Boston, MA31 studies
- Atlanta, GA25 studies
- Philadelphia, PA23 studies
- Orlando, FL19 studies
- Miami, FL18 studies
- Tampa, FL17 studies
- Chicago, IL17 studies
- Houston, TX16 studies
- San Diego, CA16 studies
- Little Rock, AR14 studies
- Las Vegas, NV13 studies
Other studies in Akron
- Non-Small Cell Lung Cancer22 studies
- Lung Cancer16 studies
- Cancer (all types)13 studies
- Breast Cancer13 studies
- Prostate Cancer9 studies
- Acute Myeloid Leukemia8 studies
- Melanoma8 studies
- Small Cell Lung Cancer8 studies
- Metastatic Cancer8 studies
- Colorectal Cancer8 studies
- Steatotic Liver Disease7 studies
- Endometrial Cancer6 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.